Combination therapy of HIV fusion entry inhibitors targeting gp41

摘要

A pharmaceutical composition for the prophylactic and therapeutic treatment of human immunodeficiency (HIV) infection comprising combinations of HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action. A kit comprising two or more HIV fusion/entry inhibitors with different target sites in HIV gp41 or different mechanisms of action is also provided.